Utilization of activated U937 monocytic cells as a model to evaluate biocompatibility and biodegradation of synthetic calcium phosphate
- 31 December 1995
- journal article
- Published by Elsevier in Biomaterials
- Vol. 16 (6) , 497-503
- https://doi.org/10.1016/0142-9612(95)98824-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Monocyte activity in the presence of calcium phosphate activated by 1,25 (OH)2 VD3 and interferon-γBiomaterials, 1994
- Phorbol ester induced osteoclast-like differentiation of a novel human leukemic cell line (FLG 29.1).The Journal of cell biology, 1992
- Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytesCellular Immunology, 1990
- Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological studyJournal of Biomedical Materials Research, 1990
- The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor.The Journal of cell biology, 1989
- Osteoclast activating factor is now interleukin‐1 beta: historical perspective and biological implicationsJournal of Oral Pathology & Medicine, 1988
- In vitro effects of calcium phosphate biomaterials on fibroblastic cell behaviorBiology of the Cell, 1987
- Biodegradation behavior of various calcium phosphate materials in bone tissueJournal of Biomedical Materials Research, 1983
- Mechanism of osteoclastic bone resorption: A new hypothesisCalcified Tissue International, 1978
- Contact-Mediated Bone Resorption by Human Monocytes in VitroScience, 1978